PROFLAZEPAM
UNII 545MN0F125

Substance Identification & Data

This profile provides standardized clinical and technical data for Proflazepam, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 545MN0F125.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 52829-30-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

545MN0F125

CAS Registry Number

52829-30-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PROFLAZEPAM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H16ClFN2O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RCDQRWWSKKYAJG-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66476

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3050433

Unique identification number in the NCBI database of chemical substances.

INN ID

3538

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1(C(CN=C(c2c1ccc(c2)Cl)c3c(cccc3)F)=O)CC(CO)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Proflazepam. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.